Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4466-4471

  Kakiya, Satoshi ^a   Murase, Takashi ^a   Arima, Hiroshi ^a   Yokoi, Hisashi ^a   Iwasaki, Yasumasa ^a   Miura, Yoshitaka ^a   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; KAPPA OPIATE RECEPTOR ANTAGONIST; MACROGOL; NALOXONE; NOCICEPTIN; NORBINALTORPHIMINE; SODIUM CHLORIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEHYDRATION; HYPEROSMOLALITY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOVOLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; WATER LOADING;

EID: 0034527321     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7809     Document Type: Article

References (42)

1. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization
2. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type
3. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene
4. Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma x glioma NG108-15 hybrid cells
5. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids
6. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
7. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor
8. Structure and regional distribution of nociceptin/orphanin FQ precursor
9. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: Its involvement in allodynic response to innocuous stimulus
10. Orphanin FQ is a functional anti-opioid peptide
11. Nociceptin or antinociceptin: Potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat
12. Naloxone sensitive orphanin FQ-induced analgesia in mice
13. Amygdaloid injections of orphanin FQ (OFQ) increase activity of the hypothalamic-pituitary-adrenal (HPA) axis
14. 14Tyr]-orphanin FQ binding
15. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat
16. Control of release of vasopressin by neuroendocrine reflexes
17. Vasopressin and oxytocin receptors
18. Inhibition of rat oxytocin and vasopressin supraoptic nucleus neurons by nociceptin in vitro
19. Inhibitory actions of nociceptin (orphanin FQ) on rat supraoptic nucleus oxytocin and vasopressin neurones in vitro
20. + conductance by orphanin-FQ/nociceptin in vasopressin-containing neurons
21. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)
22. Classification of opioid receptors
23. Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats
24. The role of blood osmolality and volume in regulating vasopressin secretion in the rat
25. Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis
26. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves
27. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat
28. Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat
29. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat
30. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat
31. Cardiovascular effects of nociceptin in unanesthetized mice
32. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
33. Regulation of pituitary ACTH secretion during chronic stress
34. Steroid hormone regulation of vasopressinergic neurotransmission in the central nervous system
35. The opioid receptor subtypes μ and κ, but not δ, are involved in the control of the vasopressin and oxytocin release in the rat
36. Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat
37. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration
38. Pharmacological assessment of the site of action of opioids on the release of vasopressin and oxytocin in the rat
39. Dynorphin-A and vasopressin release in the rat: A structure-activity study
40. Disposition of naloxone: Use of a new radioimmunoassay
41. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide
42. The ventral surface of the brain stem: A scarcely explored region of pharmacological sensitivity